Bristol Myers Squibb, schizophrenia
Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb ...
Of the more than 7.7 million people estimated to be living with sickle cell disease, more than 80% were in sub-Saharan Africa ...
The NJ SNIP grants are funded by the Bristol Myers Squibb Foundation (BMS Foundation), an independent charitable organization. Awardees of the NJ SNIP grants will receive up to $300,000 in funding ...
Analyst David Risinger of Leerink Partners reiterated a Buy rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target ...
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at ...
Valued at a market cap of $113.1 billion, Bristol-Myers Squibb Company (BMY) is a leading global biopharmaceutical company ...
A big dividend yield for a few years doesn't mean much if it can't be sustained. Even though Bristol-Myers Squibb isn't generating a profit, it is generating healthy free cash flows that easily ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback